Evidence map›Paper›PMID 26975306›Full record

ArticleJournal of medical genetics2016

Clinical features for diagnosis and management of patients with PRDM12 congenital insensitivity to pain.

Stella Zhang, Saghira Malik Sharif, Ya-Chun Chen, Enza-Maria Valente, Mushtaq Ahmed, Eamonn Sheridan, Christopher Bennett, Geoffrey Woods

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Homozygosity for a RareInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pathophysiology of Nociception and Rare Genetic Disorders with Increased Pain Threshold or Pain Insensitivity.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Review
  10. Genetic pain loss disorders.Nature reviews. Disease primers · 2022
    Review
  11. PRDM12 in Health and Diseases.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. The development of somatosensory neurons: Insights into pain and itch.Current topics in developmental biology · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Stella ZhangSchool of Clinical Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Saghira Malik SharifThe Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
Ya-Chun ChenCambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Wellcome Trust, Cambridge, UK.
Enza-Maria ValenteSection of Neurosciences, Department of Medicine and Surgery, University of Salerno, Italy.
Mushtaq AhmedThe Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
Eamonn SheridanThe Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
Christopher BennettThe Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
Geoffrey WoodsSchool of Clinical Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Wellcome Trust, Cambridge, UK.
Chapel Allerton Hospital · GBUniversity of Cambridge · GBUniversity of Salerno · ITWellcome Trust · GB

Funding

Medical Research Council MR/J012742/1
6 · The paper itself

Abstract

backgroundCongenital insensitivity to pain (CIP) is a rare extreme phenotype characterised by an inability to perceive pain present from birth due to lack of, or malfunction of, nociceptors. PRDM12 has recently been identified as a new gene that can cause CIP. The full phenotype and natural history have not yet been reported.

methodsWe have ascertained five adult patients and report their clinical features.

resultsBased on our findings, and those of previous patients, we describe the natural history of the PRDM12-CIP disorder, and derive diagnostic and management features to guide the clinical management of patients.

conclusionsPRDM12-CIP is a distinct and diagnosable disorder, and requires specific clinical management to minimise predictable complications.

Indexed as

AdultCarrier ProteinsFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedNerve Tissue ProteinsPainPain Insensitivity, CongenitalYoung AdultCarrier ProteinsNerve Tissue ProteinsPrdm12 protein, humancharcot's jointsinsensitivity to painkeratitisneuropathystaphylococcus

Identifiers

PMID26975306
PMCPMC4975812
OpenAlexW2269204402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.